Effects of ALA, EPA and DHA in high-carbohydrate, high-fat diet-induced metabolic syndrome in rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 6, 2013, Pages 1041-1052

  Poudyal, Hemant ^a   Panchal, Sunil K ^b   Ward, Leigh C ^a   Brown, Lindsay ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

Cardiovascular; Chia oil; Fish oil; Metabolic syndrome; Omega 3

Indexed keywords

ACYL COENZYME A DESATURASE; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; CARBOHYDRATE DIET; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; GLUCOSE TOLERANCE; HEART; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE VOLUME; HYPERTENSION; INSULIN SENSITIVITY; LIPID COMPOSITION; LIPID DIET; LIVER; LIVER FUNCTION; LIVER STRUCTURE; MALE; METABOLIC SYNDROME X; NONHUMAN; PLASMA; RAT; RISK FACTOR; SKELETAL MUSCLE;

ADIPOSE TISSUE; ALPHA-LINOLENIC ACID; ANIMALS; DIET, HIGH-FAT; DIETARY CARBOHYDRATES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FISH OILS; HEART; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; MUSCLE, SKELETAL; MYOCARDIUM; OBESITY; PLANT OILS; RATS; STEAROYL-COA DESATURASE;

RATTUS;

EID: 84878014437     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.07.014     Document Type: Article

References (46)

1. Anderson B.M., Ma D.W. Are all n-3 polyunsaturated fatty acids created equal?. Lipids Health Dis 2009, 8:33.
2. Bartsch H., Nair J., Owen R.W. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999, 20:2209-2218.
3. Belalcazar L.M., Reboussin D.M., Haffner S.M., Reeves R.S., Schwenke D.C., Hoogeveen R.C., et al. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care 2009, 33:197-199.
4. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15:798-808.
5. Calder P.C. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
6. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354.
7. Agatston A.S. The end of the diet debates? All fats and carbs are not created equal. Cleve Clin J Med 2005, 72:946-950.
8. Moussavi N., Gavino V., Receveur O. Could the quality of dietary fat, and not just its quantity, be related to risk of obesity?. Obesity 2007, 16:7-15.
9. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010, 91:502-509.
10. Panchal S.K., Poudyal H., Iyer A., Nazer R., Alam M.A., Diwan V., et al. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 2011, 57:611-624.
11. Poudyal H., Panchal S., Brown L. Comparison of purple carrot juice and beta-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br J Nutr 2010, 104:1322-1332.
12. Poudyal H., Campbell F., Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr 2010, 140:946-953.
13. Poudyal H., Panchal S.K., Waanders J., Ward L., Brown L. Lipid redistribution by alpha-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. J Nutr Biochem 2012, 23:153-162.
14. Panchal S.K., Poudyal H., Arumugam T.V., Brown L. Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr 2011, 141:1062-1069.
15. Poudyal H., Panchal S.K., Diwan V., Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011, 50:372-387.
16. Ratnayake W.M., Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab 2009, 55:8-43.
17. Igarashi M., DeMar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J Lipid Res 2007, 48:1150-1158.
18. Demar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J Neurochem 2005, 94:1063-1076.
19. Igarashi M., Ma K., Chang L., Bell J.M., Rapoport S.I., DeMar J.C. Low liver conversion rate of alpha-linolenic to docosahexaenoic acid in awake rats on a high-docosahexaenoate-containing diet. J Lipid Res 2006, 47:1812-1822.
20. Gao F., Kiesewetter D., Chang L., Ma K., Bell J.M., Rapoport S.I., et al. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J Lipid Res 2009, 50:749-758.
21. Barcelo-Coblijn G., Murphy E.J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res 2009, 48:355-374.
22. Ander B.P., Edel A.L., McCullough R., Rodriguez-Leyva D., Rampersad P., Gilchrist J.S., et al. Distribution of omega-3 fatty acids in tissues of rabbits fed a flaxseed-supplemented diet. Metabolism 2010, 59:620-627.
23. Patenaude A., Rodriguez-Leyva D., Edel A.L., Dibrov E., Dupasquier C.M., Austria J.A., et al. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur J Clin Nutr 2009, 63:1123-1129.
24. Fehm H.L., Kern W., Peters A. The selfish brain: competition for energy resources. Prog Brain Res 2006, 153:129-140.
25. Williams C.M., Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 2006, 65:42-50.
26. O'Donnell V.B., Maskrey B., Taylor G.W. Eicosanoids: generation and detection in mammalian cells. Methods Mol Biol 2009, 462:5-23.
27. Micha R., Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009, 5:335-344.
28. Mozaffarian D. Trans fatty acids-effects on systemic inflammation and endothelial function. Atheroscler Suppl 2006, 7:29-32.
29. Chen C.L., Tetri L.H., Neuschwander-Tetri B.A., Huang S.S., Huang J.S. A mechanism by which dietary trans fats cause atherosclerosis. J Nutr Biochem 2011, 22:649-655.
30. Bassett C.M., McCullough R.S., Edel A.L., Patenaude A., LaVallee R.K., Pierce G.N. The alpha-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am J Physiol Heart Circ Physiol 2011, 301:H2220-H2226.
31. Sacks F.M., Stone P.H., Gibson C.M., Silverman D.I., Rosner B., Pasternak R.C. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol 1995, 25:1492-1498.
32. Gronn M., Christensen E., Hagve T.A., Christophersen B.O. Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells. Biochim Biophys Acta 1991, 1081:85-91.
33. Kopecky J., Rossmeisl M., Flachs P., Kuda O., Brauner P., Jilkova Z., et al. n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 2009, 68:361-369.
34. McCullough R.S., Edel A.L., Bassett C.M., Lavallee R.K., Dibrov E., Blackwood D.P., et al. The alpha linolenic acid content of flaxseed is associated with an induction of adipose leptin expression. Lipids 2011, 46:1043-1052.
35. Garaulet M., Hernandez-Morante J.J., Lujan J., Tebar F.J., Zamora S. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans. Int J Obes 2006, 30:899-905.
36. Stump C.S., Henriksen E.J., Wei Y., Sowers J.R. The metabolic syndrome: role of skeletal muscle metabolism. Ann Med 2006, 38:389-402.
37. Flowers M.T., Ntambi J.M. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol 2008, 19:248-256.
38. Dobrzyn P., Dobrzyn A., Miyazaki M., Ntambi J.M. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. J Lipid Res 2010, 51:2202-2210.
39. Dobrzyn P., Jazurek M., Dobrzyn A. Stearoyl-CoA desaturase and insulin signaling - what is the molecular switch?. Biochim Biophys Acta 2010, 1797:1189-1194.
40. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002, 297:240-243.
41. Cohen P., Ntambi J.M., Friedman J.M. Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003, 3:271-280.
42. Hofacer R., Magrisso I.J., Jandacek R., Rider T., Tso P., Benoit S.C., et al. Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels. Prostaglandins Leukot Essent Fatty Acids 2012, 86:71-77.
43. Poudyal H., Brown L. Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity. Endocr Metab Immune Disord Drug Targets 2011, 11:217-231.
44. Hofacer R., Jandacek R., Rider T., Tso P., Magrisso I.J., Benoit S.C., et al. Omega-3 fatty acid deficiency selectively up-regulates delta6-desaturase expression and activity indices in rat liver: prevention by normalization of omega-3 fatty acid status. Nutr Res 2011, 31:715-722.
45. Deckelbaum R.J., Torrejon C. The omega-3 fatty acid nutritional landscape: health benefits and sources. J Nutr 2012, 142:587S-591S.
46. Doughman S.D., Krupanidhi S., Sanjeevi C.B. Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev 2007, 3:198-203.